Elevated S-EGFR in the breast cancer patients was associated with ER-positivity of the tumor, and a subgroup of patients with ER-positive tumors and very high levels of S-EGFR (>120 ng/mL) were identified. Here, ESR1 is linked to breast carcinoma.